University of California, Riverside | Target identified in treatment of neuroHIV

Back to the "HIV and Co-Infections News" list

Study shows how a specific brain protein causes damage during long-term HIV infection.

University of California, Riverside news release

While powerful medications can suppress the spread of HIV and its progression to AIDS, there are no cures, and many people living with HIV experience nervous system problems.

Called neuroHIV, these complications occur when HIV infection affects the function and structural integrity of the brain and, to some extent, the spinal cord and peripheral nervous system. The complications, including dementia and neuropathy, can cause problems with memory and thinking that make it hard for people to live a normal life.

Now, research has identified a brain protein driving this damage, pointing toward a possible treatment.

The research team studied the role of MAPK14, a gene integral to the inflammatory responses associated with viral infections. They found in a mouse model of neuroHIV that MAPK14’s presence and activity in a specific type of brain cell, called microglia, are required for HIV to cause brain injury and memory problems. The research is published in the journal Brain, Behavior, and Immunity.

Read the full news release here.

 

Get involved

Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?

Subscribe

Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.